The exercise period for warrants series TO 13 ("TO 13") in Alligator Bioscience AB ("Alligator Bioscience" or the "Company") (the "Warrant Programme"), issued in connection with the Company's rights ...
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH ...
Alligator Bioscience AB ( ($SE:ATORX) ) has provided an update. Alligator Bioscience has reported the preliminary outcome of its recently ...
The exercise period for warrants series TO 12 ("TO 12") in Alligator Bioscience AB ("Alligator Bioscience" or the "Company") ended on 19 May 2025. The preliminary outcome indicates that a total of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback